The Vancouver Consensus: antiretroviral medicines, medical evidence, and political will

The Vancouver Consensus: antiretroviral medicines, medical evidence, and political will

The Vancouver Consensus calls "on donors and governments to use existing resources for maximum impact and to mobilize sufficient resources globally to support ARV access for all".1 There is an urgent need to identify the resource gap required to ensure access to antiretrovirals for all peo...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) Vol. 386; no. 9993; pp. 505 - 507
Main Authors: Beyrer, Chris, Birx, Deborah L, Bekker, Linda-Gail, Barré-Sinoussi, Françoise, Cahn, Pedro, Dybul, Mark R, Eholié, Serge P, Kavanagh, Matthew M, Katabira, Elly T, Lundgren, Jens D, Mworeko, Lilian, Pala, Marama, Puttanakit, Thanyawee, Ryan, Owen, Sidibé, Michel, Montaner, Julio S G
Format: Journal Article
Language:English
Published: England Elsevier Ltd 08-08-2015
Elsevier Limited
Subjects:
Acquired immune deficiency syndrome
AIDS
Anti-Retroviral Agents - therapeutic use
Antiretroviral agents
Antiretroviral drugs
Attitude of Health Personnel
Consensus
Drug therapy
Health Policy
Health Services Accessibility
HIV
HIV Infections - epidemiology
HIV Infections - prevention & control
HIV Infections - transmission
Human immunodeficiency virus
Humans
Internal Medicine
Prevention
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Vancouver Consensus calls "on donors and governments to use existing resources for maximum impact and to mobilize sufficient resources globally to support ARV access for all".1 There is an urgent need to identify the resource gap required to ensure access to antiretrovirals for all people living with HIV and secure the funds to implement the UNAIDS 90/90/90 goals in all countries--the UNAIDS goals state that, by 2020, 90% of all people living with HIV will know their HIV status, 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy, and 90% of all people receiving antiretroviral therapy will have viral suppression.10 There is growing evidence that rapid expansion of coverage in access to antiretrovirals is not only desirable, but also possible.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(15)61458-1